Related Experiment Video
Updated: Jun 21, 2026

Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
The Utility of Transcutaneous Bilirubin Measurement in Newborns with Hyperbilirubinemia: A Prospective, Observational
Duygu Besnili Açar1, Seda Yilmaz Semerci2
1Division of Neonatology, Department of Pediatrics, Istanbul Gaziosmanpasa Training and Research Hospital, Istanbul, Turkiye.
Insights
Transcutaneous bilirubin (TcB) measurements show moderate accuracy but tend to underestimate total serum bilirubin (TSB) levels in infants receiving phototherapy. TcB should not replace TSB testing during or after treatment.
Area of Science:
- Neonatal Medicine
- Pediatric Phototherapy
- Bilirubin Metabolism
Background:
- Jaundice is common in newborns, requiring monitoring.
- Phototherapy is a standard treatment for neonatal hyperbilirubinemia.
- Accurate bilirubin measurement is crucial for effective treatment.
Purpose of the Study:
- To assess the accuracy of transcutaneous bilirubin (TcB) measurements compared to total serum bilirubin (TSB) levels.
- To evaluate TcB accuracy during and after phototherapy in term and late-preterm infants.
Main Methods:
- Prospective observational study involving 90 infants.
- Paired TcB (glabella and abdomen) and TSB measurements were collected.
- Bland-Altman analysis evaluated agreement between TcB and TSB.
Main Results:
- A moderate correlation was observed between TcB and TSB levels.
- TcB measurements consistently underestimated TSB values.
- Significant variability existed between TcB and TSB measurements.
Conclusions:
- TcB measurements have moderate agreement with TSB but are unreliable during/after phototherapy.
- TcB cannot substitute for TSB testing in this clinical context.
- Clinical decisions regarding phototherapy should rely on TSB levels.
Objective:
This study aimed to evaluate the accuracy of transcutaneous bilirubin (TcB) measurements during and after phototherapy (PT) in term and late-preterm infants.
Study Design:
In this prospective, observational study, TcB levels were measured at both the glabela (covered skin) and the lower abdomen (covered by the diaper) during treatment, then 12 and 24 hours after discontinuing the PT. Total serum bilirubin (TSB) levels were simultaneously collected through a blood sample. The agreement between TcB and TSB levels during and after PT was evaluated using Bland-Altman plots.
Results:
A total of 90 newborn infants and 540 paired bilirubin values were included in this study. The findings indicate that despite a moderate correlation with TSB levels, TcB measurements underestimate TSB levels.
Conclusion:
This study indicates a moderate correlation and agreement between TcB measurements and TSB levels in term and late-preterm infants undergoing PT, with a tendency to underestimate TSB values and considerable variability between the two methods. Hence, TcB measurements cannot be relied upon as a substitute for TSB measurements during and after PT.
Key Points:
· TcB measurements show moderate correlation with TSB levels.. · Transcutaneous bilirubin measurements tend to underestimate total serum bilirubin levels, which may lead to potential undertreatment.. · Measurements from the lower abdomen are more practical for the evaluation of TcB.. · Transcutaneous bilirubin measurement is not a reliable substitute for total serum bilirubin levels in clinical settings during and after phototherapy.. · Further studies are needed to assess the accuracy of transcutaneous bilirubin measurements beyond 24 hours post-phototherapy..
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Jaundice

